Rocket Pharmaceuticals Files Definitive Proxy Statement
Ticker: RCKTW · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Rocket Pharma filed its proxy statement for the June 18th meeting. Vote on leadership & strategy.
AI Summary
Rocket Pharmaceuticals, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 18, 2025. The company, formerly known as Inotek Pharmaceuticals Corp, is seeking shareholder approval for matters related to its corporate governance and operations. The filing indicates no fee was required for this submission.
Why It Matters
This filing provides shareholders with crucial information regarding upcoming votes on company leadership and strategic decisions, allowing them to make informed decisions at the annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- ROCKET PHARMACEUTICALS, INC. (company) — Registrant
- Inotek Pharmaceuticals Corp (company) — Former company name
- June 18, 2025 (date) — Annual meeting date
- April 30, 2025 (date) — Filing date
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Rocket Pharmaceuticals, Inc. for its annual meeting of shareholders.
When is the annual meeting scheduled to take place?
The annual meeting is scheduled for June 18, 2025.
What was Rocket Pharmaceuticals, Inc. formerly known as?
Rocket Pharmaceuticals, Inc. was formerly known as Inotek Pharmaceuticals Corp.
What is the filing date of this proxy statement?
The filing date of this proxy statement is April 30, 2025.
Was there a fee required for this filing?
No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).